Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.
D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D000596:Amino Acids / Q000032:analysis; D001921:Brain / Q000378:metabolism*; D002766:Cholecystokinin / Q000032:analysis; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003704:Dementia / Q000378:metabolism*; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010446:Peptide Fragments / Q000032:analysis; D012844:Sincalide; D013004:Somatostatin / Q000032:analysis; D013373:Substance P / Q000032:analysis
D000596:Amino Acids; D018377:Neurotransmitter Agents; D010446:Peptide Fragments; D013373:Substance P; D013004:Somatostatin; D002766:Cholecystokinin; D004299:Dopamine beta-Hydroxylase; D002795:Choline O-Acetyltransferase; D005968:Glutamate Decarboxylase; D012844:Sincalide